Glioblastoma (GBM) is a prevalent subtype of diffuse gliomas representing the most common primary adult brain cancer and one of the deadliest malignancies in humans. Despite extensive translational studies and many clinical developments, the median life
In recent times, the intersection of nanotechnology and biomedical research has given rise to nanobiomedicine, a captivating realm that holds immense promise for revolutionizing diagnostic and therapeutic approaches in the field of cancer. This innovativ
TF Cloughesy,PS Mischel - 《Clinical Cancer Research An Official Journal of the American Association for Cancer Research》 被引量: 41发表: 2011年 Overcoming therapeutic resistance in glioblastoma: the way forward Glioblastoma is the most common and lethal primary malignant brain tumor in adults. Pat...
"Research into this area is very low for several reasons. First, glioblastoma is a rare cancer so does not affect large swathes of the population. It also has extremely low survival rates and there is a long-standing history of failed studies in this area. Unfortunately, pharmaceutical compani...
ONLINE FIRST: New Glioblastoma Atlas Aims to Help Drive ResearchAn abstract is unavailable.StockwellSerena
Glioblastoma is a type of invasive malignant tumor due to the presence glioblastoma tumor stem cells, so separation of MSC mitochondria can be transferred to glioblastoma cells. Further analysis of mitochondria transfer cells can help determine the role of exogenous mitochondria in cell metabolism and ...
mobilizing the body's immune system is crucial in the context of glioblastoma because limited T-cells exist within the tumor microenvironment, said Amy Heimberger, MD, Ph.D., the Jean Malnati Miller Professor of Brain Tumor Research, vice chair for Research in the Department of Neurological Sur...
Glioblastoma: Therapeutic challenges, what lies ahead Glioblastoma (GBM) is one of the most aggressive human cancers. Despite current advances in multimodality therapies, such as surgery, radiotherapy and chem... Flavia,S R.,Lima,... - 《Biochimica Et Biophysica Acta Reviews on Cancer》 被引量...
Copyright 2019 by the Editorial Board of Chinese Journal of Contemporary Neurology and Neurosurgery.Glioma is the most common primary tumor of central nervous system (CNS), about 50% of which is extremely malignant glioblastoma (GBM). GBM is the most common primary malignant brain tumors in adults...
Scientists have found a way to inhibit the growth of glioblastoma, a type of brain cancer with low survival rates, by targeting a protein that drives growth of brain tumors, according to research from the Peter O'Donnell Jr. Brain Institute and Harold C. Simmons Comprehensive Cancer Center. ...